Answers are grounded in this paper and cite their sources.
A new series of 1-((1-phenyl-1H-1,2,3-triazol-5-yl) methyl)-2-(4-phenyl-2H-chromen-3-yl)-1H-benzo [d] imidazole (12a-n) and a library of novel imidazole-1,2,3-triazole hybrids were designed and synthesized based on the fusion pharmacophore approach. Therefore, copper (I) catalyzed click reaction of propargylated imidazole with numerous organo arylazides yielded imidazole-1,2,3-triazole hybrids 12a–n. The products were purified over column chromatography and structures of these compounds are recognized by IR, 1H-NMR, 13C-NMR and mass spectral data. All the final compounds were screened for their anti-microbial activity and the effects were matched with ciprofloxacin. Compound (12d, l, i) was the most effective compound of this series and with activities improved than ciprofloxacin under the experienced situations. Chroman-4-one scaffold is a stable structure in heterocyclic chemistry and drug conclusion.
No takes yet. Share an insight, caveat, or question.
Raghuramarao et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: